PDA

View Full Version : Neuropathic Pain Research

Pages : [1] 2
  1. Suzuki, et al. (2001): The effect of ABT-702, a novel adenosine kinase inhibitor, on the responses of spinal neurones following carrageenan inflammation and peripheral nerve injury
  2. Stubley, et al. (2001): Only early intervention with gamma-aminobutyric acid cell therapy is able to reverse neuropathic pain after partial nerve injury
  3. Catheline, et al. (2001): Intravenous morphine does not modify dorsal horn touch-evoked allodynia in the mononeuropathic rat
  4. Dai, et al. (2001): The effect of electroacupuncture on pain behaviors and noxious stimulus- evoked Fos expression in a rat model of neuropathic pain
  5. Paqueron, et al. (2001): An obligatory role for spinal cholinergic neurons in the antiallodynic effects of clonidine after peripheral nerve injury
  6. Kim, et al. (2001): Spinal cord stimulation for nonspecific limb pain versus neuropathic pain and spontaneous versus evoked pain
  7. Gard, et al. (2001): 4-Hydroxynonenal, a lipid peroxidation byproduct of spinal cord injury, is cytotoxic for oligodendrocyte progenitors and inhibits their responsiveness to PDGF
  8. Mennicken, et al. (2001): Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning
  9. Yezierski (1996): Pain following spinal cord injury: the clinical problem and experimental studies
  10. Reis & Regunathan (2000): Is agmatine a novel neurotransmitter in brain?
  11. DeLeo & Yezierski (2001): The role of neuroinflammation and neuroimmune activation in persistent pain
  12. Systemic lidocaine for neuropathic pain relief
  13. Watkins, et al. (2001): Spinal cord glia: new players in pain
  14. Vanderah, et al. (2001): Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin
  15. Boucher & McMahon (2001): Neurotrophic factors and neuropathic pain
  16. Dickinson & Fleetwood-Walker (1999): VIP and PACAP: very important in pain?
  17. Hunt (2000): Pain control: breaking the circuit
  18. Manzanares, et al. (1999): Pharmacological and biochemical interactions between opioids and cannabinoids
  19. Dellermijn (1999): Are opioids effective in relieving neuropathic pain?
  20. Carlton (2001): Peripheral excitatory amino acids
  21. Rowbotham & Petersen (2001): Zoster-associated pain and neural dysfunction
  22. Neugebauer (2001): Peripheral metabotropic glutamate receptors: fight the pain where it hurts
  23. Martin, et al. (2001): PKC-gamma Contributes to a Subset of the NMDA-Dependent Spinal Circuits That Underlie Injury-Induced Persistent Pain
  24. Wang, et al. (2001): Pronociceptive Actions of Dynorphin Maintain Chronic Neuropathic Pain
  25. Schott (2001): Delayed onset and resolution of pain
  26. von Heijne, et al. (2001): Effects of intrathecal morphine, baclofen, clonidine and R-PIA on the acute allodynia-like behaviours after spinal cord ischaemia in rats.
  27. Kingery, et al. (2001). Glucocorticoid inhibition of neuropathic hyperalgesia and spinal Fos expression
  28. Widerstrom-Noga, et al. (2001). Relationships among clinical characteristics of chronic pain after spinal cord injury.
  29. Finnerup, et al. (2001). Pain and dysesthesia in patients with spinal cord injury: A postal survey
  30. Kim, et al. (2001). Spinal cord stimulation for nonspecific limb pain versus neuropathic pain and spontaneous versus evoked pain
  31. Putzke, et al. (2001). Predictors of pain 1 year post-spinal cord injury
  32. Przewl, et al. (2001). Opioids in chronic pain
  33. Wisenfield-Hallin & Xu (2001). Neuropeptides in neuropathic and inflammatory pain with special emphasis on cholecystokinin and galanin
  34. Yashpal, et al. (2001). Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats
  35. Campbell (2001). Nerve lesions and the generation of pain
  36. Porreca, et al. (2001). Inhibition of neuropathic pain by selective ablation of brainstem medullary cells expressing the µ-opioid receptor
  37. Ha, et al. (2001). Expression of brain-derived neurotrophic factor in rat dorsal root ganglia, spinal cord and gracile nuclei in experimental models of neuropathic pain
  38. Vrinten, et al. (2001). Chronic blockade of melanocortin receptors alleviates allodynia in rats with neuropathic pain
  39. Esser, et al. (2001). Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions
  40. Putzke, et al. (2002). Long-term use of gabapentin for treatment of pain after traumatic spinal cord injury
  41. Jensen, et al. (2002). Anticonvulsants in neuropathic pain: rationale and clinical evidence
  42. Rho, et al. (2002). Complex regional pain syndrome.
  43. Attal, et al. (2002). Effects of IV morphine in central pain: A randomized placebo-controlled study.
  44. Putzke, et al. (2002). Pain classification following spinal cord injury: the utility of verbal descriptors
  45. Anand & Birch (2002). Restoration of sensory function and lack of long-term chronic pain syndromes after brachial plexus injury in human neonates.
  46. Chen, et al. (2002). Effect of 2-(phosphono-methyl)-pentanedioic acid on allodynia and afferent ectopic discharges in a rat model of neuropathic pain.
  47. Cheng, et al. (2002). DREAM is a critical transcriptional repressor for pain modulation.
  48. Bantel, et al. (2002). Intrathecal adenosine following spinal nerve ligation in rat: short residence time in cerebrospinal fluid and no change in A(1) receptor binding.
  49. Mills, et al. (2002). Group I metabotropic glutamate receptors in spinal cord injury: roles in neuroprotection and the development of chronic central pain
  50. Denkers, et al. (2002). Dorsal Root Entry Zone Lesioning Used to Treat Central Neuropathic Pain in Patients With Traumatic Spinal Cord Injury: A Systematic Review
  51. Ma & Eisenach (2002). Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain
  52. Szekely, et al. (2002). The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites
  53. Finnerup, et al. (2002). Lamotrigine in spinal cord injury pain: a randomized controlled trial.
  54. Cardenas, et al. (2002). Efficacy of amitriptyline for relief of pain in spinal cord injury: results of a randomized controlled trial
  55. Livshits, et al. (2002). Surgical treatment of painful spasticity after spinal cord injury.
  56. Chiechio, et al. (2002). L-Acetylcarnitine Induces Analgesia by Selectively Up-Regulating mGlu2 Metabotropic Glutamate Receptors.
  57. Al-Chaer ED and Traub RJ (2002). Biological basis of visceral pain: recent developments.
  58. Heiskanen, et al. (2002). Analgesic effects of dextromethorphan and morphine in patients with chronic pain.
  59. Widerstron-Noga, et al. (2002). Assessment of the impact of pain and impairments associated with spinal cord injuries
  60. Lin, et al. (2002). Induction of connexin 37 expression in a rat model of neuropathic pain.
  61. Denkers, et al. (2002). Dorsal root entry zone lesioning used to treat central neuropathic pain in patients with traumatic spinal cord injury: a systematic review.
  62. Dickenson, et al. (2002). Neurobiology of neuropathic pain: mode of action of anticonvulsants.
  63. Shubayev & Myers (2002). Anterograde TNF alpha transport from rat dorsal root ganglion to spinal cord and injured sciatic nerve.
  64. Coffey & Bruchiel (2002). Inflammatory mass lesions associated with intrathecal drug infusion catheters: report and observations on 41 patients.
  65. Olsen, et al. (2002). ReN 1869, a novel tricyclic antihistamine, is active against neurogenic pain and inflammation.
  66. Mattia, et al. (2002). New antidepressants in the treatment of neuropathic pain.
  67. Bosnjak, et al. (2002). Gabapentin for relief of neuropathic pain related to anticancer treatment: a preliminary study
  68. Ma, et al. (2002). Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury.
  69. Sorenson, et al. (2002). Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control.
  70. Aley & Levine (2002). Different peripheral mechanisms mediate enhanced nociception in metabolic/toxic and traumatic painful peripheral neuropathies in the rat.
  71. Negri, et al. (2002). Validation of Italian version of the "neuropathic pain scale" and its clinical implications.
  72. Warms, et al. (2002). Treatments for chronic pain associated with spinal cord injuries: many are tried, few are helpful.
  73. El-Khoury, et al. (2002). Attenuation of neuropathic pain by segmental and supraspinal activation of the dorsal column system in awake rats.
  74. Jancso, et al. (2002). Peripheral nerve lesion-induced uptake and transport of choleragenoid by capsaicin-sensitive c-fibre spinal ganglion neurons
  75. Pattany, et al. (2002) Proton Magnetic Resonance Spectroscopy of the Thalamus in Patients with Chronic Neuropathic Pain after Spinal Cord Injury.
  76. Hains, et al. (2002). Changes in Serotonin, Serotonin Transporter Expression and Serotonin Denervation Supersensitivity: Involvement in Chronic Central Pain after Spinal Hemisection in the Rat.
  77. Lagord, et al. (2002). Expression of TGFbeta2 but Not TGFbeta1 Correlates with the Deposition of Scar Tissue in the Lesioned Spinal Cord.
  78. Lee, et al. (2002). Upregulation of bradykinin B2 receptor expression by neurotrophic factors and nerve injury in mouse sensory neurons. Mol Cell Neurosci. 19 (2): 186-200. Summary: Brad
  79. Birklein (2002). Mechanism-based treatment principles of neuropathic pain
  80. Ma & Tian (2002). Cholera toxin B subunit labeling in lamina II of spinal cord dorsal horn following chronic inflammation in rats.
  81. Spaic, et al. (2002). Microsurgical DREZotomy for Pain of Spinal Cord and Cauda Equina Injury Origin: Clinical Characteristics of Pain and Implications for Surgery in a Series of 26 Patients
  82. Pain relief
  83. Covey, et al. (2002). Expression of neuron-associated tumor necrosis factor alpha in the brain is increased during persistent pain.
  84. Flatters, et al. (2002). Nerve injury induces plasticity that results in spinal inhibitory effects of galanin.
  85. Cizkova, et al. (2002). Neuropathic pain is associated with alterations of nitric oxide synthase immunoreactivity and catalytic activity in dorsal root ganglia and spinal dorsal horn.
  86. Friden & Lieber (2002). Mechanical considerations in the design of surgical reconstructive procedures.
  87. Covey, et al. (2002). Expression of neuron-associated tumor necrosis factor alpha in the brain is increased during persistent pain.
  88. Bantel, et al. (2002). Role of adenosine receptors in spinal g-protein activation after peripheral nerve injury.
  89. Gabapentin for neuropathic pain following spinal cord injury
  90. Lang (2002). The Role of Peripheral Benzodiazepine Receptors (PBRs) in CNS Pathophysiology.
  91. Lin, et al. (2002). Electroporation-mediated pain-killer gene therapy for mononeuropathic rats.
  92. Lin, et al. (2002). Intrathecal clonidine decreases spinal nitric oxide release in a rat model of complete Freund's adjuvant induced inflammatory pain.
  93. Lin, et al. (2002). Intrathecal spinal progenitor cell transplantation for the treatment of neuropathic pain.
  94. Xiao, et al. (2002). Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain.
  95. Thimineur, et al. (2002). Functional abnormalities of the cervical cord and lower medulla and their effect on pain: observations in chronic pain patients with incidental mild Chiari I malformation and moderate to severe cervical cord compression.
  96. Luo, et al. (2002). Injury Type-Specific Calcium Channel alpha(2)delta-1 Subunit Up-Regulation in Rat Neuropathic Pain Models Correlates with Antiallodynic Effects of Gabapentin.
  97. Sweitzer, et al. (2002). Focal peripheral nerve injury induces leukocyte trafficking into the central nervous system: potential relationship to neuropathic pain.
  98. Zahn, et al. (2002). Excitatory amino acid release in the spinal cord caused by plantar incision in the rat.
  99. Cardenas, et al. (2002). Classification of chronic pain associated with spinal cord injuries.
  100. Putzke, et al. (2002). Interference due to pain following spinal cord injury: important predictors and impact on quality of life.
  101. Yanagihara, et al. (2003). Plasma concentration profiles of ketamine and norketamine after administration of various ketamine preparations to healthy Japanese volunteers.
  102. Bhattacharya, et al. (2002). Human fetal adrenal transplant: a possible role in relieving intractable pain in advanced rheumatoid arthritis.
  103. Sumner, et al. (2003). The spectrum of neuropathy in diabetes and impaired glucose tolerance.
  104. Hewitt (2003). N-methyl-D-aspartate- enhanced Analgesia.
  105. Backonja (2003). Anticonvulsants for the treatment of neuropathic pain syndromes.
  106. Reisner (2003). Antidepressants for chronic neuropathic pain.
  107. Goddard (2002). Clinical management of the child with chronic pain.
  108. Gilron, et al. (2002). Patients' attitudes and prior treatments in neuropathic pain: A pilot study.
  109. Krames (2002). Implantable devices for pain control: spinal cord stimulation and intrathecal therapies.
  110. Curatolo & Sveticic (2002). Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination.
  111. Evans, et al. (2003). Randomized Trial of Cognitive Behavior Therapy Versus Supportive Psychotherapy for HIV-Related Peripheral Neuropathic Pain.
  112. Chong & Libretto (2003). The rationale and use of topiramate for treating neuropathic pain.
  113. Gold, et al. (2003). Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain.
  114. Gilron & Bailey (2003). Trends in opioid use for chronic neuropathic pain: a survey of patients pursuing enrollment in clinical trials
  115. Davis & Srivastava (2003). Demographics, assessment and management of pain in the elderly.
  116. Twycross, et al. (2003) Itch: scratching more than the surface.
  117. Otto, et al. (2003). Pain phenomena and possible mechanisms in patients with painful polyneuropathy.
  118. Nandi, et al. (2003). Thalamic field potentials in chronic central pain treated by periventricular gray stimulation - a series of eight cases.
  119. Obata, et al. (2003). Contribution of injured and uninjured dorsal root ganglion neurons to pain behavior and the changes in gene expression following chronic constriction injury of the sciatic nerve in rats.
  120. McMillan, et al. (2003). Catheter-associated masses in patients receiving intrathecal analgesic therapy.
  121. Erichsen, et al. (2003). A comparison of the antinociceptive effects of voltage-activated Na(+) channel blockers in two rat models of neuropathic pain.
  122. Chen & Pan (2003). Spinal nitric oxide contributes to the analgesic effect of intrathecal [d-pen2,d-pen5]-enkephalin in normal and diabetic rats.
  123. McCallum, et al. (2003). Loss of T-type calcium current in sensory neurons of rats with neuropathic pain.
  124. Ma, et al. (2003). Intrathecal lidocaine reverses tactile allodynia caused by nerve injuries and potentiates the antiallodynic effect of the COX inhibitor ketorolac.
  125. Clermont-Gnamien, et al. (2002). [The therapeutic use of D9-tetrahydrocannabinol (dronabinol) in refractory neuropathic pain].
  126. Walker, et al. (2003). The VR1 Antagonist Capsazepine Reverses Mechanical Hyperalgesia in Models of Inflammatory and Neuropathic Pain.
  127. Nicholson (2003). Responsible prescribing of opioids for the management of chronic pain.
  128. Finnerup, et al. (2003). Sensory function in spinal cord injury patients with and without central pain.
  129. Babic-Naglic, et al. (2002). [Treatment of chronic pain--use of transdermal fentanyl (Durogesic TTS)].
  130. Wallace, et al. (2002). A randomized, double-blind, placebo-controlled trial of a glycine antagonist in neuropathic pain.
  131. Vranken, et al. (2002). Continuous sacral nerve root block in the management of neuropathic cancer pain.
  132. Pandey, et al. (2002). Gabapentin for the treatment of pain in guillain-barre syndrome: a double-blinded, placebo-controlled, crossover study.
  133. Thompson (2002). Toward a pharmacoeconomic model of neuropathic pain.
  134. Dworkin (2002). An overview of neuropathic pain: syndromes, symptoms, signs, and several mechanisms.
  135. Prager (2002). Neuraxial medication delivery: the development and maturity of a concept for treating chronic pain of spinal origin.
  136. North & Wetzel (2002). Spinal cord stimulation for chronic pain of spinal origin: a valuable long-term solution.
  137. De la Calle, et al. (2002). Intrathecal transplantation of neuroblastoma cells decreases heat hyperalgesia and cold allodynia in a rat model of neuropathic pain.
  138. Garcia-Larrea, et al. (2002). Laser-evoked potential abnormalities in central pain patients: the influence of spontaneous and provoked pain.
  139. Rashid, et al. (2002). Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism.
  140. Chu, et al. (2002). Twitch-obtaining intramuscular stimulation in reflex sympathetic dystrophy.
  141. Tai, et al. (2002). Gabapentin in the treatment of neuropathic pain after spinal cord injury: a prospective, randomized, double-blind, crossover trial.
  142. Kilpatrick & Tilbrook (2002). Memantine
  143. Selak I (2001). Pregabalin (Pfizer).
  144. Widerstrom-Noga, et al. (2003). Chronic pain and nonpainful sensations after spinal cord injury: is there a relation?
  145. Haythornthwaite, et al. (2003). Factors associated with willingness to try different pain treatments for pain after a spinal cord injury.
  146. Ehde, e tal. (2003). Chronic pain secondary to disability: a review.
  147. Hefferan, et al. (2003). Spinal nerve injury activates prostaglandin synthesis in the spinal cord that contributes to early maintenance of tactile allodynia.
  148. Gerke, et al. (2003). Thalamic neuronal activity in rats with mechanical allodynia following contusive spinal cord injury.
  149. Hains, et al. (2003). Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat.
  150. Croxford, et al. (2003). Therapeutic potential of cannabinoids in CNS disease.
  151. Watkins, et al. (2003). Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain.
  152. Wade, et al. (2003). A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms.
  153. Hains, et al. (2003). Serotonin receptors 5-HT(1A) and 5-HT(3) reduce hyperexcitability of dorsal horn neurons after chronic spinal cord hemisection injury in rat.
  154. Pancaro, et al. (2003). Clonidine-induced Neuronal Activation in the Spinal Cord Is Altered after Peripheral Nerve Injury.
  155. Backonja & Glanzman (2003). Gabapentin dosing for neuropathic pain: Evidence from randomized, placebo-controlled clinical trials.
  156. Gammaitoni, et al. (2003). Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature.
  157. Ametov, et al. (2003). The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial.
  158. Feng, et al. (2003). Gabapentin markedly reduces acetic acid-induced visceral nociception.
  159. Szekely, et al. (2002). The role of ionotropic glutamate receptors in nociception with special regard to the AMPA binding sites.
  160. Sjolund (2002). Pain and rehabilitation after spinal cord injury: the case of sensory spasticity?
  161. Jorum, et al. (2003). Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
  162. Curatolo & Sveticic (2002). Drug combinations in pain treatment: a review of the published evidence and a method for finding the optimal combination.
  163. EphB receptors and ephrin-B ligands regulate spinal sensory connectivity and modulate pain processing
  164. Kaneko, et al. (2003). Does cortical motor neuron excitability change in peripheral nerve injury?
  165. Sung, et al. (2003). Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats.
  166. Putzke, et al. (2003). Test-retest reliability of the Donovan spinal cord injury pain classification scheme.
  167. Sasaki, et al. (2003). Antinociception with Intrathecal alpha-Methyl-5-Hydroxytryptamine, a 5-Hydroxytryptamine(2A/2C) Receptor Agonist, in Two Rat Models of Sustained Pain.
  168. Ciruela, et al. (2003). Identification of MEK1 as a novel target for the treatment of neuropathic pain.
  169. Holmes, et al. (2003). Transgenic overexpression of galanin in the dorsal root ganglia modulates pain-related behavior.
  170. Horiuchi, et al. (2003). Serotonergic signaling inhibits hyperalgesia induced by spinal cord damage.
  171. Han, et al. (2003). Fos expression in tyrosine hydroxylase-containing neurons in rat brainstem after visceral noxious stimulation: an immunohistochemical study.
  172. Feng, et al. (2003). Gabapentin markedly reduces acetic acid-induced visceral nociception.
  173. Mertz, et al. (2003). Visceral hypersensitivity.
  174. Stanghellini, et al. (2003). New developments in the treatment of functional dyspepsia.
  175. Kreis, et al. (2003). [Postoperative ileus: part II (clinical therapy)].
  176. Villetti, et al. (2003). Antinociceptive Activity of the N-Methyl-D- Aspartate Receptor Antagonist CHF3381 in Experimental Models of Inflammatory and Neuropathic Pain.
  177. Guenot, et al. (2003). Single-unit analysis of the spinal dorsal horn in patients with neuropathic pain.
  178. Kakigi, et al. (2003). Cerebral responses following stimulation of unmyelinated C-fibers in humans: electro- and magneto-encephalographic study.
  179. Tanaka, et al (2003). Local cooling alters neural mechanisms producing changes in peripheral blood flow by spinal cord stimulation.
  180. Mannes, et al. (2003). Cystatin C as a cerebrospinal fluid biomarker for pain in humans.
  181. Suzuki-Yamamoto, et al. (2003). Immunocytochemical localization of prostaglandin F synthase II in the rat spinal cord.
  182. Hellstrom, et al. (2003). Large cholinergic nerve terminals on subsets of motoneurons and their relation to muscarinic receptor type 2.
  183. Stewart & Maxwell (2003). Distribution of and organisation of dorsal horn neuronal cell bodies that possess the muscarinic m2 acetylcholine receptor.
  184. Barrett, et al. (2003). Pain characteristics in patients admitted to hospital with complications after spinal cord injury.
  185. Kim, et al. (2003). Effects of morphine on mechanical allodynia in a rat model of central neuropathic pain.
  186. Yap, et al. (2003). Pain during in-patient rehabilitation after traumatic spinal cord injury.
  187. Siddall, et al. (2003). A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury.
  188. Sawynok & Liu (2003). Adenosine in the spinal cord and periphery: release and regulation of pain.
  189. Zhang, et al. (2003). Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models.
  190. Marchettini, et al. (2003). The Lindblom roller.
  191. Beric (2003). Spinal cord injury pain.
  192. South, et al. (2003). A conditional deletion of the NR1 subunit of the NMDA receptor in adult spinal cord dorsal horn reduces NMDA currents and injury-induced pain.
  193. Komar, et al. (2003). Scheuermann's kyphosis following cervical spinal cord injury
  194. Backonja & Glanzman (2003). Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials.
  195. Haderer, et al. (2003). Cutaneous analgesia after transdermal application of amitriptyline versus lidocaine in rats.
  196. Eisenberg & Brecker (2002). Lumbar spinal cord stimulation for cervical-originated central pain: a case report.
  197. Colpaert, et al. (2002). Large-amplitude 5-HT1A receptor activation: a new mechanism of profound, central analgesia.
  198. Finnerup, et al. (2002). Anticonvulsants in central pain.
  199. Hemstapat, et al. (2003). Morphine-3-glucuronide's neuro-excitatory effects are mediated via indirect activation of N-methyl-D-aspartic acid receptors: mechanistic studies in embryonic cultured hippocampal neurones.
  200. Kim, et al. (2003). Effects of morphine on mechanical allodynia in a rat model of central neuropathic pain.
  201. Holtman, et al. (2003). Modification of morphine analgesia and tolerance by flumazenil in male and female rats.
  202. Pain Trials for Spinal Cord Injuries
  203. Hains, et al. (2003). Upregulation of Sodium Channel Nav1.3 and Functional Involvement in Neuronal
  204. Ma, et al. (2003). Intrathecal injection of cAMP response element binding protein (CREB) antisense
  205. Back, et al. (2003). Ascending pathways for mechanical allodynia in a rat model of neuropathic pain
  206. Lim, et al. (2003). Upregulation of spinal cannabinoid-1-receptors following nerve injury enhances
  207. Lavand'homme & Eisenach (2003). Perioperative administration of the alpha2-adrenoceptor agonist clo
  208. Walker, et al. (2003). Neonatal inflammation and primary afferent terminal plasticity in the rat do
  209. Manfredi, et al. (2003). Neuropathic pain in patients with cancer.
  210. Cannabis-Based Medicines
  211. Caudle, et al. (2003). N-methyl-D-aspartate receptor subunit expression and phosphorylation followi
  212. Zhu & Eisenach (2003). Cyclooxygenase-1 in the spinal cord is altered after...
  213. Wu, et al. (2003). The very-high-efficacy 5-HT(1A) receptor...allodynia-like...spinal cord injury
  214. Hughes, et al. (2003). ...Sprouting of A{beta} Afferents ...Spinal Cord Dorsal Horn...Nerve Section
  215. Widerstrom-Noga & Turk (2003). ...effectiveness of treatments... chronic pain... spinal cord injury
  216. Wu, et al. (2003). A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates...
  217. Wu, et al. (2003). Systemic galnon, a low-molecular weight galanin receptor agonist, reduces....
  218. Sekiguchi, et al. (2003). ISSLS Prize: Erythropoietin Inhibits Spinal Neuronal Apoptosis & Pain...
  219. Management of chronic central neuropathic pain following traumatic spinal cord injury:
  220. Narita, et al. (2004). Neuronal protein kinase Cgamma-dependent proliferation and hypertrophy
  221. Neuropathic pain..exactly what is it?
  222. Kvarnstrom, et al. (2004). Intravenous ketamine versus lidocaine, double-blind crossover trial.
  223. Hama & Urban (2004). Cannabinoid agonist effects on pain in rats
  224. Brumovsky, et al. (2004). Constriction of sciatic nerves increase pain and NPY receptor expression
  225. Taylor & McCarson (2004). Neurokinin-1 receptor expression in mouse spinal cords with pain
  226. Narita, et ak, (2004). Morphine effects of chronic pain mediated through dopaminergic systems
  227. Ghilardi, et al. (2004). COX-2 participated in peripheral nerve injury induced hyperalgesia
  228. Narita, et al. (2004). Spinal PKC blockade reduces neuropathic pain in rats
  229. Dorn, et al. (2004). siRNA relieves chronic neuropathic pain. N
  230. Aoki, et al. (2004). DRG axons innervating lumbar discs in rats
  231. Kim, et al. (2004). Electroacupuncture effect on allodynia in rat neuropathic pain model
  232. Xu, et al. (2004). Neuropathic pain activates endogenous opioid kappa receptors and tolerance
  233. Yezierski, et al. (2004). Spinal neurons responsible for "at-level" pain in rats after SCI
  234. Russo (2004). Clinical Endocannabinoid Deficiency (CECD)
  235. Obata, et al. (2004). Degeneration of motor and sensory fiber, neurotrophic factors, and pain
  236. Brown, et al. (2004). NGF distribution in injured rat spinal cords
  237. Block, et al. (2004). Mechanism-based therapies for pain.
  238. Research for SCI Pain
  239. Help me please
  240. c3 stenosis
  241. Baseline inconsistency problems using the Hargreaves PWL test??!!
  242. Outpatient Research Study
  243. Rashid & Ueda (2005). Pre-injury administration of morphine prevents development of neuropathic...
  244. Song, et al. (2005). Intracellular messengers contributing to neuropathic pain in SCI
  245. Dai, et al. (2005). CAM Kinase II contributes to neuropathic pain in rats
  246. Christoph, et al. (2005) Anti-allodynic effects of NMDA glycine antagonists
  247. Schwab, et al (2005). Spinal cord injury induces early and persistent lesional P2X4 receptor expres
  248. Kunz, et al. (2005). … proteomic analysis of rat spinal cord in inflammatory and neuropathic pain
  249. Hulsebosch (2005). …treatment strategies for central neuropathic pain after spinal cord injury.
  250. Finnerup, et al. (2005). Intravenous lidocaine relieves spinal cord injury pain…